We’re committed to ensuring that appropriate patients prescribed our medicines are able to access them. The inLighten® Patient Support program offers educational resources and other support to eligible patients throughout this process and their treatment journey.
For those seeking access to our investigational therapies, we offer the potential for managed access pathways.
At Insmed, one of the ways that we support people living with serious diseases is through early, ongoing, and transparent collaboration with patients and providers.
To learn more about our advocacy efforts and get in touch with our team, contact
advocacy@insmed.com.
© 2026 Insmed Incorporated. All Rights Reserved.